Immunovant Inc (IMVT)
26.86
-1.94%
Immunovant Inc (IMVT) is currently trading at $26.86. This represents a loss of 1.94% from the previous session. With a market capitalization of $5.50B, IMVT is a key component of the Health Care sector. Investors looking to trade IMVT should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade IMVT commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Immunovant Inc (IMVT) shows a bearish trend. Analysts are watching the 29.25 level closely.
Fundamentals
Mkt Cap5.50B
P/E Ratio0.0000
Volume1,164,507
60-Day Technical Chart
Advanced Charting
Need more indicators for IMVT? Use the world's #1 platform.
Open IMVT on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $27
| Metric |
IMVT -1.94% |
T -1.32% |
PFE -0.63% |
WBD -0.51% |
|---|---|---|---|---|
| Price | $26.86 | $27.98 | $26.97 | $29.00 |
| Mkt Cap | $5.50B | $196.89B | $153.46B | $71.90B |
| - | View → | View → | View → |
Latest Headlines
Is Immunovant (IMVT) Overvalued? Taking Stock of Its Premium Price-to-Book Multiple
Yahoo Finance • Dec 2, 2025
Immunovant (Nasdaq: IMVT) raises $550M to support potential IMVT-1402 Graves’ launch
Stock Titan • Dec 11, 2025
Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets
TechStock² • Dec 14, 2025
Roivant Sciences buys Immunovant (IMVT) shares worth $349.9m
Investing.com • Dec 12, 2025
$IMVT stock is up 13% today. Here's what we see in our data.
Quiver Quantitative • Oct 27, 2025
● Gemini Agentic AI Analyst Insight for IMVT
Market Education
- Understanding Hedge Fund Alpha and Beta: A Guide for New Investors Jun 2, 2024
- October Market Volatility: Why Investors Fear the “Danger Month” Sep 26, 2025
- From Small Players to Market Movers: How Former Small Caps Are Scaling Up Sep 27, 2025
External Research